Synthesis and Biological Properties of Novel PATEs
J ournal of Medicinal Chemistry, 1999, Vol. 42, No. 1 85
(10) Gorelick, R. J .; Chabot, D. J .; Ott, D. E.; Gagliardi, T. D.; Rein,
A.; Henderson, L. E.; Arthur, L. O. Genetic analysis of the zinc
finger in the Moloney leukemia virus nucleocapsid domain:
replacement of zinc-coordinating residue with other zinc-
coordinating residues yields noninfectious particles containing
genomic RNA. J . Virol. 1996, 70, 2593-2597.
(11) Dorfman, T.; Luban, J .; Goff, S. P.; Haseltine, W. A.; Go¨ttlinger,
H. G. Mapping of functionally important residues of a cysteine-
histidine box in the human immunodeficiency virus type 1
nucleocapsid protein. J . Virol. 1993, 67, 6159-6169.
(12) Kra¨usslich, H. G.; Fa¨cke, M.; Heuser, A.-M.; Konvalinka, J .;
Zentgraph, H. The spacer peptide between human immunode-
ficiency virus capsid and nucleocapsid proteins is essential for
ordered assembly and viral infectivity. J . Virol. 1995, 69, 3407-
3419.
(13) Darlix, J .-L.; Vincent, A.; Gabus, C.; De Rocquigny, H.; Roques,
B. Trans-activation of the 5′ to 3′ viral DNA strand transfer by
nucleocapsid protein during reverse transcription of HIV-1 RNA.
C. R. Acad. Sci. III 1993, 316, 763-771.
(28) Rice, W. G.; Turpin, J . A.; Huang, M.; Clanton, D.; Buckheit, R.
W., J r.; Covell, D. G.; Wallqvist, A.; McDonnel, N. B.; DeGuzman,
R. N.; Summers, M. F.; Zalkow, L.; Bader, J . P.; Haugwitz, R.
D.; Sausville, E. A. Azodicarbonamide inhibits HIV-1 replication
by targeting the nucleocapsid protein. Nature Med. 1997, 3, 341-
345.
(29) Rice, W. G.; Turpin, J . A.; Schaeffer, C. A.; Graham, L.; Clanton,
D.; Buckheit, R. W., J r.; Zaharevitz, D.; Summers, M. F.;
Wallqvist, A.; Covell, D. G. Evaluation of selected chemotypes
in coupled cellular and molecular target-based screens identified
novel HIV-1 zinc finger inhibitors. J . Med. Chem. 1996, 39,
3606-3616.
(30) Tummino, P. J .; Harvey, P. J .; McQuade, T.; Domagala, J .;
Gogliotti, R.; Sanchez, J .; Song, Y.; Hupe, D. The human
immunodeficiency virus type 1 (HIV-1) nucleocapsid protein zinc
ejection activity of disulfide benzamides and benzoisothiazolo-
nes: correlation with anti-HIV-1 and virucidal activities. Anti-
microb. Agents Chemother. 1997, 41, 394-400.
(31) Loo, J . A.; Holler, T. P.; Sanchez, J .; Gogliotti, R.; Maloney, L.;
Reily, M. D. Biophysical characterization of zinc ejection from
HIV nucleocapsid protein by anti-HIV 2,2′-dithiobis[benzamides]
and benzoisothiazolones. J . Med. Chem. 1996, 39, 4313-4320.
(32) Domagala, J . M.; Bader, J . P.; Gogliotti, R. D.; Sanchez, J . P.;
Stier, M. A.; Song, Y.; Prasad, J . V. N. V.; Tummino, P. J .;
Scholten, J .; Harvey, P.; Holler, T.; Gracheck, S.; Hupe, D.; Rice,
W. G.; Schultz, R. A new class of anti-HIV-1 agents targeted
toward the nucleocapsid protein NCp7: the 2,2′-dithiobisben-
zamides. Bioorg. Med. Chem. 1997, 5, 569-579.
(14) Li, X.; Quan, Y.; Arts, E. J .; Preston, B. D.; De Rocquigny, H.;
Roques, B. P.; Darlix, J .-L.; Klieman, L.; Parniak, M. A.;
Wainberg, M. A. Human immunodeficiency virus type 1 nucleo-
capsid protein (NCp7) directs specific initiation of minus-strand
Lys
DNA synthesis primed by human tRNA3 in vitro: studies of
viral RNA molecules mutated in regions that flank the primer
binding site. J . Virol. 1996, 70, 4996-5004.
(15) Carteau, S.; Batson, S. C.; Poljak, L.; Mouscadet, J . F.; de
Rocquigny, H.; Darlix, J . L.; Roques, B. P.; Kas, E.; Auclair, C.
Human immunodeficiency virus type 1 nucleocapsid protein
specifically stimulates Mg2+-dependent DNA integration in vitro.
J . Virol. 1997, 71, 6225-6229.
(33) Summers, M. F.; Henderson, L. E.; Chance, M. R.; Bess, J . W.,
J r.; South, T. L.; Blake, P. R.; Sagi, I.; Perez-Alvarado, G.;
Sowder, R. C., III; Hare, D. R.; Arthur, L. O. Nucleocapsid zinc
fingers detected in retroviruses: EXAFS studies on intact
viruses and the solution-state structure of the nucleocapsid
protein from HIV-1. Protein Sci. 1992, 1, 563-576.
(16) Zybarth, G.; Carter, C. Domains upstream of the protease (PR)
in human immunodeficiency virus type 1 Gag-Pol influence PR
autoprocessing. J . Virol. 1995, 69, 3878-3884.
(17) Gorelick, R. J .; Chabot, D. J .; Rein, A.; Henderson, L. E.; Arthur,
L. O. The two zinc fingers in the human immunodeficiency virus
type 1 nucleocapsid protein are not functionally equivalent. J .
Virol. 1993, 67, 4027-4036.
(18) Lapadat-Tapolsky, M.; De Rocquigny, H.; Van Gent, D.; Roques,
B.; Plasterk, R.; Darlix, J .-L. Interactions between HIV-1 nucleo-
capsid protein and viral DNA may have important functions in
the viral life cycle. Nucleic Acid Res. 1993, 21, 831-839.
(19) Rice, W. G.; Schaeffer, C. A.; Graham, L.; Bu, M.; McDougal, J .
S.; Orloff, S. L.; Villinger, F.; Young, M.; Oroszlan, S.; Fesen,
M. R.; Pommier, Y.; Mendeleyev, J .; Kun, E. The site of action
of 3-nitrosobenzamide on the infectivity process of human
immunodeficiency virus in lymphocytes. Proc. Natl. Acad. Sci.
U.S.A. 1993, 90, 9721-9724.
(20) Rice, W. G.; Supko, J . G.; Malspeis, L.; Buckheit, R. W., J r.;
Clanton, D. J .; Bu, M.; Graham, L.; Schaeffer, C. A.; Turpin, J .
A.; Domagala, J .; Gogliotti, R.; Bader, J . P.; Halliday, S. M.;
Coren, L.; Sowder, R. C., II; Arthur, L. O.; Henderson, L. E.
Inhibitors of HIV nucleocapsid protein zinc fingers as candidates
for the treatment of AIDS. Science 1995, 270, 1194-1197.
(21) Rein, A. D.; Ott, D. E.; Mirro, J .; Arthur, L. O.; Rice, W. G.;
Henderson, L. E. Inactivation of murine leukemia virus by
compounds that react with the zinc finger in the viral nucleo-
capsid protein. J . Virol. 1996, 70, 4966-4972.
(34) Goodford, P. J . A computational procedure for determining
energenically favorable binding sites on biologically important
macromolecules. J . Med. Chem. 1985, 28, 849-857.
(35) Wallqvist, A.; J ernigan, R. L.; Covell, D. G. A preference-based
free-energy parametrization of enzyme-inhibitor binding: ap-
plications to HIV-1 protease inhibitor design. Protein Sci. 1995,
4, 1881-1903.
(36) Covell, D. G.; J ernigan, R. L.; Wallqvist, A. Structural analysis
of inhibitor binding to HIV-1 protease: identification of a
common binding motif. THEOCHEM 1998, 423, 93-100.
(37) Wallqvist, A.; Covell, D. G. Docking enzyme-inhibitor complexes
using a preference based free-energy surface. Proteins 1996, 25,
403-419.
(38) Kosower, E. M. Molecular Biochemistry; McGraw-Hill: New
York, 1962; pp 166-219.
(39) van Eys, J .; Kaplan, N. The addition of sulfhydryl compounds
to the diphosphopyridine nucleotide and its analogues. J . Biol.
Chem. 1957, 228, 305-314.
(40) Katritsky, A.; Chen, J .; Wittman, D.; Marson, C. Formation of
sigma and pi or charge -transfer complexes from pyridinium
cations. J . Org. Chem. 1986, 51, 2481-2485.
(41) Mendez, F.; Gazquez. The Fukui function of an atom in
molecule: criterion to characterize the reactive sites of
chemical species. Proc. Ind. Acad. Sci. 1994, 106, 183-193.
a
a
(22) Turpin, J . A.; Terpening, S. J .; Schaeffer, C. A.; Yu, G.; Glover,
C. J .; Felsted, R. L.; Sausville, E. A.; Rice, W. G. Inhibitors of
human immunodeficiency virus type 1 zinc fingers prevent
normal processing of Gag precursors and result in the release
of noninfectious virus particles. J . Virol. 1996, 70, 6180-6189.
(23) Turpin, J . A.; Schaeffer, C. A.; Terpening, S. J .; Graham, L.; Bu,
M.; Rice, W. G. Reverse transcription of human immunodefi-
ciency virus type 1 is blocked by retroviral zinc finger inhibitors.
Antiviral Chem. Chemother. 1997, 8, 60-69.
(24) Huang, M.; Maynard, A.; Covell, D. G.; J anini, G. M.; Graham,
L.; Turpin, J . A.; Rice, W. G. Anti-HIV-1 agents that selectively
target retroviral nucleocapsid protein zinc fingers without
affecting cellular zinc finger proteins. J . Med. Chem. 1998, 41,
1371-1381.
(42) Doddi, G.; Ercolani, G.; Mencarelli, P. The problem of regiose-
lectivity in nucleophilic additions to pyridinium and related
cations: role of generalized anomeric effect. J . Org. Chem. 1992,
57, 4431-4434.
(43) Clanton, D. J .; Buckheit, R. W., J r.; Terpening, S. J .; Kiser, R.;
Mongelli, N.; Borgia, A. L.; Schultz, R.; Narayanan, V.; Bader,
J . P.; Rice, W. G. Novel sulfonated and phosphonated analogues
of distamycin which inhibit the replication of HIV. Antiviral Res.
1995, 27, 335-354.
(44) Bader, J . P.; McMahon, J . B.; Schultz, R. J .; Narayanan, V. L.;
Pierce, J . B.; Harrison, W. A.; Weislow, O. S.; Midelfort, C. F.;
Stinson, S. F.; Boyd, M. R. Oxathiin carboxanilide, a potent
inhibitor of human immunodeficiency virus reproduction. Proc.
Natl. Acad. Sci. U.S.A. 1991, 88, 6740-6744.
(25) Maynard, A. T.; Huang, M.; Rice, W. G.; Covell, D. G. Reactivity
of the HIV-1 nucleocapsid protein p7 zinc finger domains from
the perspective of density-functional theory. Proc. Natl. Acad.
Sci. U.S.A. 1998, 95, 11578-11583.
(26) Hathout, Y.; Fabris, D.; Han, M. S.; Sowder, R. C., II; Henderson,
L. E.; Fenselau, C. Characterization of intermediates in the
oxidation of zinc fingers in human immunodeficiency virus type
1 nucleocapsid protein P7. Drug Metab. Dispos. 1997, 24, 1395-
400.
(27) Rice, W. G.; Baker, D.; Schaeffer, C. A.; Graham, L.; Bu, M.;
Terpening, S.; Clanton, D.; Schultz, R.; Bader, J . P.; Buckheit,
R. W., J r.; Field, L.; Singh, P. K.; Turpin, J . A. Inhibition of
multiple phases of HIV-1 replication by a dithiane compound
that attacks the conserved zinc fingers of retroviral nucleocapsid
proteins. Antimicrob. Agents Chemother. 1997, 41, 419-426.
(45) Kageyama, S.; Mimoto, T.; Murakawa, Y.; Nomizu, M.; Ford,
H., J r.; Shirasaka, T.; Gulnik, S.; Erickson, J .; Takada, K.;
Hayashi, H.; Broder, S.; Kiso, Y.; Mitsuya, H. In vitro anti-
human immunodeficiency virus (HIV) activities of transition
state mimetic HIV protease inhibitors containing allophenyl-
norstatine. Antimicrob. Agents Chemother. 1993, 37, 810-817.
(46) Buckheit, R. W., J r.; Roberson, J . L.; Lackman-Smith, C.; Wyatt,
J . R.; Vickers, T. A.; Ecker, D. J . Potent and specific inhibition
of HIV envelope-mediated cell fusion and virus binding by G
quartet-forming oligonucleotide (ISIS 5320). AIDS Res. Hum.
Retroviruses 1994, 10, 1497-1506.
(47) Turpin, J . A.; Buckheit, R. W., J r.; Derse, D.; Hollingshead, M.;
Williamson, K.; Palamone, C.; Osterling, M. C.; Hill, S. A.;
Graham, L.; Schaeffer, C. A.; Bu, M.; Huang, M.; Cholody, W.
M.; Michejda, M. J .; Rice, W. G. Inhibition of acute-, latent-, and